(Q71647537)
Statements
Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance (English)
A. de Vries-van Der Zwan
A. C. Besseling
F. Kievits
E. van Twuyver
1 September 1994